Âé¶¹Éçmadou

Drug Trends has identified, crawled (or ‘scraped’), extracted, categorised and analysed drug listings on cryptomarkets on a regular basis since 1st February 2014. This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month period. The current bulletin focuses on analysis of drug listings on cryptomarkets from June 2024 to May 2025.

An accompanying public is available, allowing viewers to interact with data collected over the total monitoring period.

Key findings

  • From 1st June 2024 to 31st May 2025, 15 cryptomarkets were monitored, of which 14 remained active at the end of the reporting period.
  • The two markets reaching more than 10,000 listings in a snapshot during this period were Archetyp and Abacus.
  • There were 22,839 and 39,554 drug listings per snapshot in June 2024 and May 2025, respectively, with a significant increase of 5.1% per month in the drug market size during the 12-month period.
  • Cannabis comprised the greatest percentage of drug listings from June 2024 to May 2025 (26.2%), followed by MDMA (8.2%), benzodiazepines (8.1%), opioids (excluding heroin) (7.5%), cocaine (6.9%), and meth/amphetamine (illicit) (6.1%).
  • The market share of PIEDs/weight loss drugs showed the highest rate of increase from 4.7% in June 2024 to 7.2% in May 2025. The greatest significant rate of decrease in market share was observed for meth/amphetamines, from 6.4% in June 2024 to 5.7% in May 2025.

Recommended citation

Man, N., Sutherland, R., Barratt, M. J., Bruno, R., Sadaphale, V., & Peacock, A. (2025). Trends in the availability and type of drugs sold on the internet via cryptomarkets, June 2024 - May 2025. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, Âé¶¹Éçmadou Sydney. Available from:

Funding and copyright

Drug Trends is supported by funding from the Australian Government Department of Health, Disability and Ageing under the Drug and Alcohol Program.

©NDARC, Âé¶¹Éçmadou SYDNEY 2025 

This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and enquiries concerning reproduction and rights should be addressed to the information manager, NDARC, Âé¶¹Éçmadou Sydney, NSW 2052, Australia via drugtrends@unsw.edu.au.

Date published

31 Jul 2025

Resource type

Drugs and New Technologies (DNeT) bulletins

Download these resources

Contact

Research areas